RNAse L RIBOTAC
RNAse L RIBOTAC (compound C64) is an RNA-degrading chimera which binds to a four-way RNA helix called SL5 in the 5’ UTR of the SARS-CoV-2 RNA genome and inhibits the virus replication in lung epithelial carcinoma cells. (Blue: RNA ligand (HY-168456) ; Black: linker (HY-130591) ; Pink: Rnase L ligand (HY-168457) ) [1]
Product Specifications
UNSPSC
12352005
Target
PROTACs
Related Pathways
PROTAC
Field of Research
Infection
Smiles
O=C(C(C/1=O)=C(NC2=CC=CC=C2)SC1=C/C3=CC=C(OCCOCCN4N=NC(COCCOCCOCCOCCOC5=CC6=NC(C(C7=O)=CC8=C(O7)C=C(N9CCNCC9)C=C8)=CN6C=C5)=C4)C(O)=C3)OCC
Molecular Formula
C55H60N8O13S
Molecular Weight
1073.18
References & Citations
[1]Tang Z, et al. Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region. Nat Commun. 2025 Jan 8;16 (1) :483.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-168455/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
